3D Medicines: Xia Fang Confirmed as Qualified Company Secretary; Li Ching Yi to Step Down in June 2026

Bulletin Express

Jun 30

3D Medicines Inc. announced that the Hong Kong Stock Exchange has confirmed the qualification of current Joint Company Secretary Xia Fang to serve as the company’s sole company secretary under Listing Rules 3.28 and 8.17. This confirmation follows a previously granted waiver that allowed Xia to act in the role from the company’s listing on 15 December 2022 until 14 December 2025.

\n\nWith Xia’s qualification now formally recognised, Joint Company Secretary and Authorised Representative Li Ching Yi has tendered her resignation from both positions, effective 30 June 2026. On the same date, Xia will assume the additional duty of Authorised Representative under Listing Rule 3.05.

\n\nAccording to the filing, Li confirmed she has no disagreement with the Board and that no matters regarding her departure need to be brought to shareholders’ attention. The Board expressed its gratitude for her contributions during her tenure.

\n\nAs of the announcement date, the Board consists of one executive director, three non-executive directors and three independent non-executive directors, chaired by Dr. Gong Zhaolong.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1104413194"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1104413194\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1104413194?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 21:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104413194","market":"us","top_or_hot":-1,"title":"3D Medicines: Xia Fang Confirmed as Qualified Company Secretary; Li Ching Yi to Step Down in June 2026","media":"Bulletin Express","content":"<p>3D Medicines Inc. announced that the Hong Kong Stock Exchange has confirmed the qualification of current Joint Company Secretary Xia Fang to serve as the company’s sole company secretary under Listing Rules 3.28 and 8.17. This confirmation follows a previously granted waiver that allowed Xia to act in the role from the company’s listing on 15 December 2022 until 14 December 2025.</p>\n<p>\\n\\nWith Xia’s qualification now formally recognised, Joint Company Secretary and Authorised Representative Li Ching Yi has tendered her resignation from both positions, effective 30 June 2026. On the same date, Xia will assume the additional duty of Authorised Representative under Listing Rule 3.05.</p>\n<p>\\n\\nAccording to the filing, Li confirmed she has no disagreement with the Board and that no matters regarding her departure need to be brought to shareholders’ attention. The Board expressed its gratitude for her contributions during her tenure.</p>\n<p>\\n\\nAs of the announcement date, the Board consists of one executive director, three non-executive directors and three independent non-executive directors, chaired by Dr. Gong Zhaolong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3D Medicines: Xia Fang Confirmed as Qualified Company Secretary; Li Ching Yi to Step Down in June 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3D Medicines: Xia Fang Confirmed as Qualified Company Secretary; Li Ching Yi to Step Down in June 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-30 21:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>3D Medicines Inc. announced that the Hong Kong Stock Exchange has confirmed the qualification of current Joint Company Secretary Xia Fang to serve as the company’s sole company secretary under Listing Rules 3.28 and 8.17. This confirmation follows a previously granted waiver that allowed Xia to act in the role from the company’s listing on 15 December 2022 until 14 December 2025.</p>\n<p>\\n\\nWith Xia’s qualification now formally recognised, Joint Company Secretary and Authorised Representative Li Ching Yi has tendered her resignation from both positions, effective 30 June 2026. On the same date, Xia will assume the additional duty of Authorised Representative under Listing Rule 3.05.</p>\n<p>\\n\\nAccording to the filing, Li confirmed she has no disagreement with the Board and that no matters regarding her departure need to be brought to shareholders’ attention. The Board expressed its gratitude for her contributions during her tenure.</p>\n<p>\\n\\nAs of the announcement date, the Board consists of one executive director, three non-executive directors and three independent non-executive directors, chaired by Dr. Gong Zhaolong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01244","symbol_name":"思路迪医药股份","start_time":0,"source_url":"","article_id":"1104413194","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104413194","pubTimestamp":1782827021,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"3D Medicines Inc. announced that the Hong Kong Stock Exchange has confirmed the qualification of current Joint Company Secretary Xia Fang to serve as the company’s sole company secretary under...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01244":"思路迪医药股份"},"translate_title":"3D Medicines：夏芳确认为合格公司秘书；李静仪将于2026年6月卸任","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01244":1},"content_text":"3D Medicines Inc. announced that the Hong Kong Stock Exchange has confirmed the qualification of current Joint Company Secretary Xia Fang to serve as the company’s sole company secretary under Listing Rules 3.28 and 8.17. This confirmation follows a previously granted waiver that allowed Xia to act in the role from the company’s listing on 15 December 2022 until 14 December 2025.\n\\n\\nWith Xia’s qualification now formally recognised, Joint Company Secretary and Authorised Representative Li Ching Yi has tendered her resignation from both positions, effective 30 June 2026. On the same date, Xia will assume the additional duty of Authorised Representative under Listing Rule 3.05.\n\\n\\nAccording to the filing, Li confirmed she has no disagreement with the Board and that no matters regarding her departure need to be brought to shareholders’ attention. The Board expressed its gratitude for her contributions during her tenure.\n\\n\\nAs of the announcement date, the Board consists of one executive director, three non-executive directors and three independent non-executive directors, chaired by Dr. Gong Zhaolong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}